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The objective of this study was to investigate the effect of Ramadan fasting on body mass index (BMI) 
and on certain biochemical parameters of serum in women patients with non-insulin dependent 
diabetes mellitus. Sixty-six subjects from 3 regions located in the west of Algeria participated in this 
study. All participating patients were studied a week before Ramadan and at the third week of Ramadan 
fasting. No statistically significant fluctuations were noted in BMI either during Ramadan or in non-
fasting days. However, the rates of glycosylated haemoglobin (HbA1c) decreased slightly (P < 0.05) 
during the last week of the month of Ramadan among the diabetic patients. Also, the glucose levels 
were significantly (p < 0.05) higher in the serum subjects of patients during the fasting period when 
compared to the level before Ramadan. This could be due to the significant decrease (P < 0.05) of 
insulin levels in patients during the fasting period. The rates of HDL cholesterol recorded in the blood 
among patients rose significantly (p < 0.05) during the Ramadan than during the non-fasting period. The 
statistically significant increase in HDL-cholesterol explains clearly the beneficial effect of Ramadan 
fasting on diabetic’s serum lipids. Moreover, serum total cholesterol, triglyceride, LDL cholesterol and 
VLDL cholesterol levels decreased significantly (p < 0.05) during the third week of Ramadan than non-
fasting day. As for proteinous compounds (protein, creatin and urea), their plasmatic rates all increased 
substantially (p < 0.05) in patients during the fasting period of the month of Ramadan.  
 





Ramadan is the ninth month of the lunar calendar obser-
ved each year by more than one billion muslims world-
wide, during which all healthy adult muslims abstain from 
eating, drinking, smoking and having sexual intercourse 
from sunrise to sunset. Sick or traveling people, as well 
as breast-feeding or menstruating women, are tempo- 
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After the condition that precluded fasting resolves, 
exempted individuals have to compensate for the number 
of days they did not fast, even though the Ramadan 
month is over. The time of observance differs each year 
because it is a lunar calendar and as such, fasting from 
dawn to sunset occurs at a period that varies with the 
geographical site and the season. In summer months and 
northern latitudes, the fast could last up to eighteen hours 
or more. During Ramadan, muslims typically eat two 
meals each day. The first is taken immediately following 
the evening call to  prayer  after  sunset  and the  other  is 




typically eaten just before the commencement of the daily 
fast. 
Research that tried to investigate the positive effect of 
fasting as well as its innocuousness has shown very sup-
portive evidence especially in the treatment of a number 
of metabolic disorders, such as diabetes (type 2) which 
result from two interdependent anomalies. The first of 
which is the resistance to insulin where a lesser sensi-
tivity is displayed by the relevant cells (adipose tissue, 
liver and muscles) and the second is a lesser hormonal 
secretion by the pancreas in response to a high glucose 
rate in the blood (Rodier, 2001). 
Despite numerous studies evidencing the beneficial 
attributes of fasting, its use for medicinal purposes 
remains controversial. Some believe it is a dangerous 
and unhealthy practice whereas others advance that this 
physiological rest is essential to a good healthy life style. 
Broadly, fasting provides a moment of respite to the 
organism wherein different organs can recover, a reason 
that can prop up this practice in the case of certain illness 
of metabolic nature. Also, we acknowledge its benefits in 
purifying the body from toxins and functions that were 
disturbed by over-eating, malnutrition or a bad intake of 
nutriments. Furthermore it is an efficient way of preven-
ting certain diseases and assure a better hormonal 
balance (Afifi, 1997; Fakhrazadeh et al., 2003) 
Based on current knowledge, majority of studies on 
type 2 diabetes (DNID) in relation to the fasting Ramadan 
month were done on sick male subjects with less work  
been undertaken on females (Azizi and Rasouli, 1987; 
Laajam, 1990; Al Hader et al., 1994; Athar and Habib, 
1994; Dehgan et al., 1994; Ewis and Afifi, 1997; Al Nakhi 
et al., 1997; Bougerra et al., 1997; Klocker et al., 1997; 
Khatib, 1997; Uysal et al., 1997; Sulimani et al.,1999). 
The purpose of this study was to follow the effect of the 
fasting Ramadan month on the variations of the blood 
glucose and certain serum lipids in women type 2 diabe-
tic patients treated with Biguanides with age range of 45-
53 years and BMI higher than 27 kg/m2. 
 
 




The trial population comprised muslim women with type 2 diabetes 
(according to WHO criteria) that practiced Ramadan fasting (World 
Health Organization and Expert Committee on Diabetes, 1985). An 
explanatory session was given by the investigators in both French 
and Arabic languages and written consent was received from each 
willing participant. Sixty-six patients treated with Biguanides from 
three Regions (Mostaganem, Mascara and Relizane) located in the 
West of Algeria participated in this study. Their ages ranged from 
45-53 years (mean ± SD = 48.73 ± 2.22) and had a BMI of 27.40 ± 
03.08 kg/m2 (mean ± SD). Patients were excluded from the trial if 
they had cardiac disease (congestive heart failure, angina pectoris, 
previous myocardial infarction), impaired kidney or liver function, 
severe uncontrolled hypertension, severe diabetic complications, or 
had received therapy with insulin or other investigational drugs that 
reduces lipidic catabolism such as oral contraception and corticos- 










The study was performed in October 2003, which coincided with the 
holy month of Ramadan. All participating patients were studied a 
week before Ramadan and at the third week of Ramadan fasting. 
10 ml of blood sample was withdrawn from 12 h fasting subjects by 
venipuncture into dry tubes for the pre-fasting period. To respect 
the 10-12 h fast in the pre-Ramadan period, the blood sampling 
during Ramadan must be done at 1300 h. Samples were allowed to 
clot and the serum centrifuged, divided into aliquots and stored at -
18oC until analyzed. On both test days, glucose, glycosylated hae-
moglobin (HbA1c), insulin, triglycerides, high-density lipoprotein 
cholesterol (HDL-c), low density lipoprotein cholesterol (LDL-c), pro-
teins, creatinin and urea were measured from each of the sixty-six 
blood samples. During Ramadan, the subjects slept uninterruptedly 
from 0200 to 0800 h and their average sleep time was thus 1 h 
shorter during Ramadan than it had been during the control period. 
Daily working hours in Ramadan are from 0900 to 1500 h; but on 





Anthropometric measurements were performed on subjects in light 
clothing and without shoes. Height was measured to the nearest 
0.5 cm and body weight was measured on a level balance 
calibrated daily and recorded to the nearest 0.1 kg. Body mass 
index (BMI) was calculated as weight (kg) divided by height (m) 
squared (Tchobrousky and Guy-Grand, 1997). Blood samples were 
drawn after at least 12 h of fasting for determination of serum levels 
of glucose, total cholesterol (Tot-c), high-density lipoprotein choles-
terol (HDL-c) and triglycerides (TG), proteins (P), creatinin (C) and 
urea by enzymatic methods using Merck reagent kits and Elan 
2000 autoanalyser. High density lipoprotein cholesterol (HDL-c) 
was measured in the supernatant after precipitation of apolipo-
protein B-containing lipoproteins with dextran sulfate and magne-
sium chloride. LDL cholesterol was calculated with the Friedewald 
formula [LDL-c = Tot-C-(TG/5 + HDL-c)] when triglycerides 
concentrations were <5.0 mmol/L. Subjects with triglycerides levels 
>5.0 mmol/L were excluded (Friedewald et. al., 1972). Procedure 
for the separation and measurement of the percentage of HbAlc 
glucosylated haemoglobin in blood samples, in which a)  haemoly-
sate is obtained from  blood sample; b) the said haemolysate is 
used to impregnate a weak cationic exchange resin; c) a first buffer 
solution is passed through the resin to effect the selective elution of 
the glucosylated haemoglobins HbAla and HbAlb; d) a second 
buffer solution is passed through the resin to effect the selective 
elution of the HbAlc glucosylated haemoglobin; and e) if required, 
the HbA1c content of the collected eluate is analysed and com-
pared with the total haemoglobin present in the haemolysate 
(Schnek and Schroeder, 1961). To remove antibody-bound insulin, 
plasma was prepared immediately after venipuncture, mixed with 
an equal volume of 30% polyetheylene glycol and centrifuged 
immediately (Hanning et. al., 1985). Plasma free insulin was mea-
sured by radioimmuno assay (Soeldner and Slone, 1965). Trained 
interviewers administered a structured questionnaire to collect 





Data were analyzed using the StatBox 6 and were expressed as 
mean and standard deviation (SD). Parametric values were compared 
with one way ANOVA and student’s t test. The level (p < 0.05) was 
considered as the cut-off value for significance. 




Table 1. Change in body mass index, serum glucose and glycosylated haemoglobin (HbA1c) 
in type 2 diabetic patients. 
 
Parameters Pre-Ramandan Ramandan P -value 
Body mass index (Kg/m2) 27.395 ± 03.082 27.568 ± 03.546 0.36636 
Glucose level (g/L) 01.847 ± 00.200 01.983 ± 00.171 0.00002 
HbA1c (%) 09.520 ± 03.272 08.748 ± 03.251 0.00078 
 


























Body mass index (BMI), blood glucose and 
glycosylated haemoglobin (HbA1c) 
 
A total of sixty-six patients with type 2 diabetes, aged 
48.73 ± 2.22 years (mean ± SD) were randomized and 
received a medical treatment in Biguanides. The BMI, 
measured one week before fasting and third week of 
Ramadan fasting did not change significantly (mean 
values ± SD = 27.40 ± 03.55 vs. 27.57 ± 03.08 Kg/m2). 
Concerning the glucose levels in the blood, the average 
values recorded were significantly (p < 0.05) higher in the 
serum of subjects during the fasting period (01.98 ± 
00.17 [mean ± SD] g/L) when compared to the level be-
fore Ramadan (01.85 ± 00.20 [mean ± SD] g/L). By com-
parison at the period before the Ramadan, the rates of 
glycosylated haemoglobin (HbA1c) decreased slightly at 
P < 0.05 from 9.52 to 8.74% among the diabetic patients 
during the last week of the month of Ramadan. This is 





In general, during Ramadan the average content of plas-
ma insulin among diabetic women were significantly 
lowered than during the non-fasting period at P < 0.05. 
The values obtained were  14.62 ± 02.79 vs. 11.97 ± 
02.48 U/ml (mean values ± SD) (Figure 1).  
Lipidic measurements 
 
Values of HDL cholesterol in the blood were statistically 
higher (P < 0.05) in Ramadan (00.67 ± 00.29] g/L) than 
the first period before the Ramadan (00.56 ± 00.17 g/L). 
Moreover, serum total cholesterol, triglyceride, LDL cho-
lesterol and VLDL cholesterol levels decreased remark-
ably (P < 0.05) during the third week of Ramadan than 
during the non-fasting days (01.84 ± 00.47, 01.49 ± 
00.21, 00.91 ± 00.37 and 00.30 ± 00.04 vs 02.10 ± 00.47, 
01.77 ± 0.30, 01.22 ± 00.53 and 00.36 ± 00.06 g/L) 





During Ramadan, the average content of plasma proteins 
among diabetic patients were remarkably higher than 
during the non-fasting period (P < 0.05); (mean values ± 
SD = 80.34 ± 04.75 vs. 73.80 ± 03.25 g/L). Plasma 
creatin content were insignificantly higher in the second 
period (that is, Ramadan) with a value of (9.51 ± 1.23 mg/ 
L) compared to (8.47 ± 1.35 mg/L) in the first period 
before fasting. Finally, urea was statistically (P < 0.05) 
more important during fasting than non fasting period; 





During the  month  of  Ramadan  fasting,  muslims  world  




Table 2. Changes in lipid levels in type 2 diabetic patients. 
 
Lipid level (g/L) Pre-Ramandan Ramandan P -value 
Total cholesterol  02.101 ± 00.473 01.836 ± 00.473 0.00004 
Triglyceride  01.769 ± 00.304 01.489 ± 00.213 0.00001 
HDL cholesterol  00.557 ± 00.165 00.67 1 ± 00.285 0.00015 
LDL cholesterol   01.219 ± 00.527 00.906 ± 00.374 0.00003 
VLDL cholesterol  00.356 ± 00.060 00.298 ± 00.043 0.00001 
 
Values were expressed as mean±SD. HDL = high-density lipoprotein; LDL = low-density 




Table 3. Change in proteinous parameters in type 2 diabetic patients. 
 
Proteinous parameters level (g/L) Pre-Ramandan Ramandan P -value 
Proteins 73.801 ± 03.251 80.340 ± 04.750 0.00650 
Creatinin 08.471 ± 01.230 09.510 ± 01.230 0.26000 
Urea 00.255 ± 00.031 00.291 ± 00.031 0.00325 
 




wide consume two meals between sunset and dawn and 
there is no restriction on the amount or type of food eaten 
at night (Laajam, 1990; Salman et al., 1992). People may 
alter their sleeping habits and smoking is limited to night 
time only. Furthermore, most diabetics reduce their daily 
activities during this period out of fear of hypoglycemia 
(Laajam, 1990; Ewis and Afifi, 1997). These factors may 
certainly explain not only a lack of weight loss, but also a 
weight gain in such patients. It appeared that in the study 
conducted, the women with non-insulin dependent dia-
betes mellitus (NIDM, Type 2 Diabetes) did not present a 
weight loss during the Ramadan fasting, their body mass 
index (BMI) levels remains relatively high and maintained 
fairly close than before fasting period. A review of lite-
rature showed controversy about BMI changes in dia-
betics of male sex during Ramadan. In one group of 
studies, patients had an increase in their BMI (Rashed, 
1992; Klocker et al., 1997). In another group, there were 
no changes (Laajam, 1990; Ewis and Afifi, 1997; Uysal et 
al., 1997; Sulimani et al., 1999) while still others reported 
decrease in BMI (Azizi and Rasouli, 1987; Mafauzy et al., 
1990; Athar and Habib, 1994; El Ati et al., 1995; Al Nakhi 
et al., 1997; Khatib, 1997). According to El Ati et al. 
(1995), the reduction in the insulin concentration during 
fasting could be an adaptive mechanism with the 
safeguarding of the standard weight. In addition, it is well 
established that the treatments with the Biguanides are 
often prescribed to the type 2 diabetes showing an over-
load of weight (Ralph and DeFronzo, 1999). 
 
 
Blood glucose and glycosylated haemoglobin 
(HbA1c) 
 
In respect to most cases, no episode of acute  complications  
(hypoglycemic or hyperglycemic types) occured in 
patients under medical treatment with the Biguanides and 
only a few cases of biochemical hypoglycemia with-out 
clinical hazards has been reported. The present results 
suggest the possibility that increased blood glu-cose 
levels at the third week of Ramadan may be related to 
increased gluconeogenesis. These results are in line with 
those of (Nagra and Giliani, 1991) who reported a 10% 
increase in glucose level towards the end of Ramadan in 
adult’s males and attributed it to gluconeo-genesis. The 
glycemia levels noted during the fasting un-doubtedly 
results from hepatic overproduction of glucose following 
an activation of the gluconeogenesis in order to 
compensate for the fall in glycogenolysis (Meyer et al., 
1998). Other studies had shown significant decrease in 
blood glucose towards the end of the fasting month and it 
was explained by the subjects’ intake of hypocaloric 
meals (Malhotra et al., 1989). The findings are also 
contrary to those announced by Muazzam and Khalique 
(1959), Angel and Schwartz (1975) and Iraki et al. (1997) 
who found non significant change in blood glucose during 
this period. These differences may be attributed generally 
to the amount or type of food consumed, changes in body 
weight, regularity of taking medications and decreased 
physical activities during the fast (Gwinup et al., 1963; 
Koren et al., 1987). From these studies, one may assume 
that during the fasting days which follow a rather large 
meal taken before dawn (Sahur), the stores of glycogen, 
along with some degrees of gluconeogenesis maintain 
serum glucose within normal limits. From the period be-
fore the fasting to Ramadan period, the results showed a 
significant reduction (P > 0.05) of the rate of glycosylated 
haemoglobin (HbA1c) among diabetic patients treated 
with Biguanides. Several studies had shown that serum 





1994; Belkhadir et al., 1994; Sulimani, 1997; Sulimani et 
al.,1999; Farad Bensenouciet et al., 2002; Azizi and 
Siahkolah, 2003; Yarahmadi et al., 2003; Sari et al., 
2004) did not change during Ramadan fasting. Other stu-
dies suggested that HbA1c levels decreased during this 
month (Mafauzy et al., 1990; Sulimani et al., 1999; 
Gustaviani et al., 2004). The reduction in the rate of 
glycosylated haemoglobin (HbA1c) is a proof justifying 
the beneficial effect of the medicinal treatment taken 
during the Ramadan fasting. The glycosylated haemo-
globin results from a slow and irreversible nonenzymatic 
fixation of glucose (or other oses) on haemoglobin during 
the lifespan of the red globules of blood. This denomina-
tion definitively replaced the unsuitable term of glycosyled 
haemoglobin; the glycosylation is an enzymatic mecha-
nism of proteinic biosynthesis (ANAES, 2000). The HbA 
1c is henceforth recognized as the only reference dosage 
use to ascertain balance of diet consumed by the 
diabetics, of therapeutic measurements to undertake and 
the necessity in certain situations to modify the treatment 
to reach the objectives recommended among the patients 
(Drouin et al., 1999; ANAES, 2000). The rate of HbA1c is 
directly proportional to the concentration of glucose in 
blood. It is independent of the daily variations of the gly-
caemia and is not affected by physical exercise, fasting 
or recent ingestion of sugar. Its dosage among patients 
does not require 12 h of fasting (ANAES, 2000). At the 
second period of the month of Ramadan, a rather signifi-
cant reduction in the rates of HbA1c which thus testify to 
the beneficial action of the medicinal treatment under-
taken by the patients particularly during the period of 
fasting was recorded. Each point gained on the reduction 
of HbA1c results in an unquestionable clinical benefit, as 
suggested by majority of preliminary studies (ANAES, 
2000). The D.C.C.T (diabetes control and complications 
trial) advances the same ideas in which a reduction in 
HbA1c remarkably decreases the risks of specific compli-
cations among the diabetic patients (Drouin et al., 1999). 
Also, the UKDPS (UKPDS, 1998) has noted clearly the 
clinical benefit which can bring back significantly a 
plasmatic reduction of 1% of HbA1c in terms of reduction 
in the risk of micro and macro vascular complications 





As seen in this study, LDL-cholesterol was lower in the 
serum of 21 day Ramadan compared to levels before 
Ramadan. Also, HDL-cholesterol levels were higher in 
the serum subjects at the end Ramadan compared to 
levels before Ramadan. These results were in agreement 
with those reported by certain authors on healthy persons 
(Leake and Rankin, 1990; Maislos et al., 1993; Aldouni et 
al., 1998; Temizhan et al., 2000; Toda and Morimoto, 
2000). Few studies have reported increases in high den-
sity   lipoprotein   (HDL)   cholesterol  in  diabetics  during  




Ramadan (Dehgan et al., 1994; Khatib, 1997; Uysal et 
al., 1997). One report indicated an increase in low density 
lipoprotein (LDL) cholesterol and decrease in HDL-
cholesterol (Bougerra et al., 1997). These variations 
certainly result from the differences in the food habits and 
the composition of meal consumed by the studied popu-
lations. Recent data reported by Lacono and Dougherty 
(1991) have shown that ingestion of poly unsaturated 
fatty acid (PUFA) in fat diet reduces LDL–cholesterol 
without affecting HDL-cholesterol, when the PUFA 
percentage is not higher than 11% of total energy intake. 
It appears that the increase of HDL-c values during the 
third week of fasting coincides with the reduction of blood 
VLDL-c levels. The increase in the hydrolysis of hepatic 
VLDL-c undoubtedly favored the synthesis of the HDL-c 
at the diabetics (Basdevant, 1994). The previous data 
concerning HDL-cholesterol explain clearly the beneficial 
effect of Ramadan fasting on serum lipids of diabetics. 
Serum total cholesterol and triglyceride levels 
decreased significantly (P< 0.05) towards the end of the 
study. Most patients with NIDDM showed no change or 
slight decrease in concentration of total cholesterol and 
triglyceride (Al Hader et al., 1994; Dehgan et al., 1994; Al 
Nakhi et al., 1997; Bougerra et al., 1997; Ewis and Afifi, 
1997; Klocker et al., 1997; Khatib, 1997; Uysal et al., 
1997). Concerning the healthy subjects, it seems that 
total cholesterol levels increased during Ramadan fasting 
whilst triglyceride levels were unaffected (Fedail et al., 
1982). Other studies (Gwinup et al., 1963; Irwin and 
Feeley, 1967; Gumaa et al., 1978; Fedail et al., 1982; 
Shokry MI, 1986; El-Hazmi et al., 1987) have reported in-
creased levels of serum cholesterol or triglycerides levels 
at the end of Ramadan fasting. In all, changes in blood 
lipids observed seem to be variable and depend probably 
on the quality and quantity of food consumption and the 
degree of weight changes. It has been recently shown 
that consumption of low fat diet induces a decrease in 
serum cholesterol concentration only when accompanied 
by body weight loss (Lichtenstein, 1994). In fact, some 
studies have suggested a correlation between weight lost 
and decrease in total cholesterol levels (Sakr, 1975). In 
addition, the increase in the glucose levels during the 
fasting undoubtedly reduced the catabolism and the 
significant mobilization of the triglycerides from peripheric 
tissues to plasmatic circulation. These results may be 
also explained by different food habits of the studied 
populations and the type of food consumed during 
Ramadan as there is a tendency towards increased 





Comparing the benchmark period (non fasting period), a 
more significant level of proteins in the serum was found 
during Ramadan among patients treated with Biguanides. 
This can be the result of over-expression  of  certain  hor- 




mones during prolonged fasting periods, such as gluca-
gon which can stimulate a higher mobilization of some 
constituents of peripheral tissues such as amino acids 
(Jensen et al., 1998). This amino acid surge is usually 
caused by the need to compensate through glucogenesis 
the deficit in glucose in the peripheral tissues (Herman et 
al., 2000). According to Herman et al. (2000) protein le-
vels have the same patterns as BMI and thus muscular 
mass. This has been confirmed by the results gotten from 
this study where patients following Biguanides treatment 
have a higher values of BMI particularly during the 
Ramadan fasting.  
Concerning urea, the average values during the entire 
course of the experiment were within the range found in a 
healthy person (0.15 to 0.5 g/l). Albeit during fasting, urea 
rates were significantly higher among Biguanides users. 
This might be the cause of the slight dehydration due to 
abstinence from drinking during fasting period which led 
to a fall in diuresis and a consequent rise in urea in the 
blood (Bonneau, 2001). Also ammoniac discharge 
following desamination and disamidation of certain amino 
acids used in the process of neoglucogenesis is the pri-
mary cause of an intense synthesis of hepatic urea 
(Nagra et al., 1998). There was a clear rise in creatinin 
during Ramadan, among Biguanides users. This can be 
explained by an absent in protein mobilization and/or low 
renal clearance. Lacour (1992) indicated that creatinin 
does not depend only on glomerular filtration but also on 
certain food substances rich in this element such as meat 
product whose consumption probably increases during 





The insulin rates decreased significantly (P < 0.05) in dia-
betic women during the Ramadan compared to the period 
before the fasting. These results were in agreement with 
those advanced by Sadr et al. (2001) and Al arouj et al. 
(2005). In contrast, Bagraic et al. (1994) suggested that 
plasma insulin and C-peptide levels do not change during 
the Ramadan fasting. According to a recent study, these 
two variables were reported not to have changed in 
women but to decrease in men (Yarahmadi et al., 2003). 
When bloods samples are taken at 4 h interval, the 
results showed that plasma insulin and C-peptide level 
increased at 08:00 h and decrease later in the day 
(Khatib and Shafagoj, 2004). Insulin resistance decrease 
in both genders during Ramadan, but this change was 
significant only in men (Yarahmadi et al., 2003). 
The reduction in the insulin secretion is probably the 
most important phenomenon endocrine function during 
the food fasting. Its weak production accompanied by a 
notable secretion of glucagons during the month of 
Ramadan are undoubtedly the principal elements allow-
ing the activation of  lipolysis, the start up of  gluconeo-
genesis and muscular proteolysis (Barrè et al., 2001; 





ing, the maintenance of a certain plasmatic insulin pro-
duction undoubtedly avoids the exaggerated manifest-
tation of certain metabolic reactions such as lipolysis and 





In conclusion, it appears that the holy month of Ramadan 
fasting was not harmful to the health of diabetic women 
studied. It however showed a beneficial effect on the 
evolution of glycosylated haemoglobin and certain 
studied lipidic parameters such as HDL-c and LDL-c. It 
would be extremely interesting to know if the Ramadan 
fasting affects the atherogenic lipoproteinic particles (LP 
B, LP B:E, LP B:CIII, among others), particularly in obese 
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